Immunogen (IMGN) 10-Q2008 Q1 Quarterly report

Filed: 7 Nov 07, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: accelerated, acceleration, accrued, assumption, build, Cambridge, carry, check, Code, commence, commencing, construction, corporate, corporation, declared, deliverable, delivered, deposit, depreciation, direct, disposition, Employer, escalation, executory, Exhibit, experienced, exposed, FAS, federal, filer, Food, formation, fourth, headcount, Intercontinental, laboratory, large, lead, leasehold, lessee, lessor, located, MA, met, multiplying, NOL, nonperformance, nonrefundable, notice, occupy, offer, offering, ownership, Oxley, par, past, percentage, physical, post, practicable, pre, preceding, prosecution, purpose, ratified, reached, Reform, relevant, Rule, satisfactory, shell, shorter, shown, sublease, taxable, trend, vendor, Waltham, Washington, wholly, Winter, written

Removed: accrual, accumulated, achieve, acquisition, acute, addressed, adjust, advancing, amend, assumed, authority, billed, Biotech, Boehringer, British, burdened, call, cantuzumab, competitive, conduct, conducted, conference, connection, considerable, consistent, context, contractually, convertible, create, cumulative, decide, decided, deferral, deficit, derecognition, design, devote, devoted, dilutive, disposable, effector, encounter, enhance, ensure, EORTC, equally, evaluating, examination, exclude, excluded, executed, extension, Factor, failing, GmbH, Growth, high, history, improved, improving, inclusion, incorrect, individual, Ingelheim, initiated, International, introduced, invest, investigated, Kingdom, largest, lesser, leukemia, likelihood, March, marketed, marketing, measured, mertansine, microorganism, modified, Molecular, myeloid, myeloma, negotiation, obligation, oncology, overcome, participate, percent, planned, plc, Prague, prepared, profitability, profitable, proposed, prospectively, PSMA, qualify, ratably, receiving, Receptor, refer, regained, relinquished, remedy, residual, resolved, responsibility, retained, reverse, rollforward, routine, SAR, satisfied, seek, settlement, Sizeable, statute, step, successfully, sufficient, supporting, sustain, sustained, tabular, targeting, technological, test, therapeutic, threshold, ultimate, United, utility, variance, version, viability, viable, work, write

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

IMGN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of ImmunoGen, Inc., a Massachusetts corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report for the period ended September 30, 2007 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 7, 2007	/s/ MITCHEL SAYARE
	Mitchel Sayare
	Chairman of the Board of Directors, Chief Executive Officer and President

Dated: November 7, 2007	/s/ DANIEL M. JUNIUS
	Daniel M. Junius
	Executive Vice President and Chief Financial Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.